BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 36989843)

  • 1. miRNAs as potential game-changers in melanoma: A comprehensive review.
    Abd-Allah GM; Ismail A; El-Mahdy HA; Elsakka EGE; El-Husseiny AA; Abdelmaksoud NM; Salman A; Elkhawaga SY; Doghish AS
    Pathol Res Pract; 2023 Apr; 244():154424. PubMed ID: 36989843
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Significance of miRNAs on the thyroid cancer progression and resistance to treatment with special attention to the role of cross-talk between signaling pathways.
    Doghish AS; El-Mahdy HA; Ismail A; Hegazy M; Mokhtar MM; Elkhawaga SY; Elkady MA; Yehia AM; Elsakka EGE
    Pathol Res Pract; 2023 Mar; 243():154371. PubMed ID: 36791561
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An emphasis on the interaction of signaling pathways highlights the role of miRNAs in the etiology and treatment resistance of gastric cancer.
    Fathi D; Elballal MS; Elesawy AE; Abulsoud AI; Elshafei A; Elsakka EGE; Ismail A; El-Mahdy HA; Elrebehy MA; Doghish AS
    Life Sci; 2023 Jun; 322():121667. PubMed ID: 37023952
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Beneficial and detrimental aspects of miRNAs as chief players in breast cancer: A comprehensive review.
    Ismail A; El-Mahdy HA; Abulsoud AI; Sallam AM; Eldeib MG; Elsakka EGE; Zaki MB; Doghish AS
    Int J Biol Macromol; 2023 Jan; 224():1541-1565. PubMed ID: 36328268
    [TBL] [Abstract][Full Text] [Related]  

  • 5. miRNAs as potential game-changers in head and neck cancer: Future clinical and medicinal uses.
    El-Mahdy HA; Mohamadin AM; Abulsoud AI; Khidr EG; El-Husseiny AA; Ismail A; Elsakka EGE; Mokhlis HA; El-Husseiny HM; Doghish AS
    Pathol Res Pract; 2023 May; 245():154457. PubMed ID: 37058745
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Epigenetic regulation of miRNA genes and their role in human melanomas.
    Perera RJ; Ray A
    Epigenomics; 2012 Feb; 4(1):81-90. PubMed ID: 22332660
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The role of miRNAs in laryngeal cancer pathogenesis and therapeutic resistance - A focus on signaling pathways interplay.
    Hegazy M; Elkady MA; Yehia AM; Elsakka EGE; Abulsoud AI; Abdelmaksoud NM; Elshafei A; Abdelghany TM; Elkhawaga SY; Ismail A; Mokhtar MM; El-Mahdy HA; Doghish AS
    Pathol Res Pract; 2023 Jun; 246():154510. PubMed ID: 37167812
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Aberrations in the micro-RNA biogenesis machinery and the emerging roles of micro-RNAs in the pathogenesis of cutaneous malignant melanoma.
    Leibowitz-Amit R; Sidi Y; Avni D
    Pigment Cell Melanoma Res; 2012 Nov; 25(6):740-57. PubMed ID: 22958787
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The interplay of signaling pathways and miRNAs in the pathogenesis and targeted therapy of esophageal cancer.
    Doghish AS; El-Husseiny AA; Abdelmaksoud NM; El-Mahdy HA; Elsakka EGE; Abdel Mageed SS; Mahmoud AMA; Raouf AA; Elballal MS; El-Dakroury WA; AbdelRazek MMM; Noshy M; El-Husseiny HM; Abulsoud AI
    Pathol Res Pract; 2023 Jun; 246():154529. PubMed ID: 37196470
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The role of miRNAs in the pathogenesis and therapeutic resistance of endometrial cancer: a spotlight on the convergence of signaling pathways.
    Abdelmaksoud NM; El-Mahdy HA; Ismail A; Elsakka EGE; El-Husseiny AA; Khidr EG; Ali EM; Rashed MH; El-Demerdash FE; Doghish AS
    Pathol Res Pract; 2023 Apr; 244():154411. PubMed ID: 36921547
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of Regulatory Oncogenic or Tumor Suppressor miRNAs of PI3K/AKT Signaling Axis in the Pathogenesis of Colorectal Cancer.
    Soleimani A; Rahmani F; Ferns GA; Ryzhikov M; Avan A; Hassanian SM
    Curr Pharm Des; 2018; 24(39):4605-4610. PubMed ID: 30636581
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ultraviolet radiation-induced differential microRNA expression in the skin of hairless SKH1 mice, a widely used mouse model for dermatology research.
    Singh A; Willems E; Singh A; Ong IM; Verma AK
    Oncotarget; 2016 Dec; 7(51):84924-84937. PubMed ID: 27793049
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The role of microRNAs in melanoma.
    Luo C; Weber CE; Osen W; Bosserhoff AK; Eichmüller SB
    Eur J Cell Biol; 2014; 93(1-2):11-22. PubMed ID: 24602414
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Molecular mechanisms underlying the action of carcinogens in gastric cancer with a glimpse into targeted therapy.
    Patrad E; Khalighfard S; Amiriani T; Khori V; Alizadeh AM
    Cell Oncol (Dordr); 2022 Dec; 45(6):1073-1117. PubMed ID: 36149600
    [TBL] [Abstract][Full Text] [Related]  

  • 15. miRNAs as cornerstones in colorectal cancer pathogenesis and resistance to therapy: A spotlight on signaling pathways interplay - A review.
    Elrebehy MA; Al-Saeed S; Gamal S; El-Sayed A; Ahmed AA; Waheed O; Ismail A; El-Mahdy HA; Sallam AM; Doghish AS
    Int J Biol Macromol; 2022 Aug; 214():583-600. PubMed ID: 35768045
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MicroRNAs and the PTEN/PI3K/Akt pathway in gastric cancer (Review).
    Hu M; Zhu S; Xiong S; Xue X; Zhou X
    Oncol Rep; 2019 Mar; 41(3):1439-1454. PubMed ID: 30628706
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of microRNAs in the main molecular pathways of hepatocellular carcinoma.
    Vasuri F; Visani M; Acquaviva G; Brand T; Fiorentino M; Pession A; Tallini G; D'Errico A; de Biase D
    World J Gastroenterol; 2018 Jul; 24(25):2647-2660. PubMed ID: 29991871
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MicroRNA-22 targets FMNL2 to inhibit melanoma progression via the regulation of the Wnt/β-catenin signaling pathway and epithelial-mesenchymal transition.
    Shi L; Huo JW; Chen SS; Xue JX; Gao WY; Li XY; Song YH; Xu HT; Zhu XW; Chen K
    Eur Rev Med Pharmacol Sci; 2019 Jun; 23(12):5332-5342. PubMed ID: 31298385
    [TBL] [Abstract][Full Text] [Related]  

  • 19. miR-101-2, miR-125b-2 and miR-451a act as potential tumor suppressors in gastric cancer through regulation of the PI3K/AKT/mTOR pathway.
    Riquelme I; Tapia O; Leal P; Sandoval A; Varga MG; Letelier P; Buchegger K; Bizama C; Espinoza JA; Peek RM; Araya JC; Roa JC
    Cell Oncol (Dordr); 2016 Feb; 39(1):23-33. PubMed ID: 26458815
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Update on melanoma epigenetics.
    de Unamuno B; Palanca S; Botella R
    Curr Opin Oncol; 2015 Sep; 27(5):420-6. PubMed ID: 26197354
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.